Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1991-03-12
1993-03-23
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514 81, 5142328, 514320, 514403, 544140, 546187, 546199, 548113, 548369, 548370, A01N 4356, A01N 5732, C07D 2354, C07F 924
Patent
active
051964082
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
The following publications disclose pyrazolines:
______________________________________ U.S. Pat. No. 4,070,365
EPA 21,506
U.S. Pat. No. 4,156,007
EPA 58,424
U.S. Pat. No. 4,174,393
EPA 65,334
U.S. Pat. No. 4,663,341
EPA 113,213
WO 88/05046 EPA 153,127
WO 88/07994 EPA 286,346
WO 89/00562 EPA 300,692
______________________________________
Grosscurt et al., J. Agric Food Chem., Vol. 27, No. 2 (1979).
SUMMARY OF THE INVENTION
This invention pertains to compounds of Formulae I, II and III, including all geometric and stereoisomers, agriculturally suitable salts thereof, compositions containing them and their use as arthropodicides in agricultural and home uses. Hereafter, the compounds, isomers and salts are referred to as compound(s) for the sake of simplicity. The compounds are: ##STR2## wherein
A is a 1, 2 or 3-atom bridge comprising 0 to 3 carbon atoms, 0 to 1 oxygen atoms, NR.sub.6, or S(O)q, wherein each carbon individually can be substituted with 1 to 2 substituents selected from 1 to 2 halogen, C.sub.1 to C.sub.6 alkyl, C.sub.2 to C.sub.4 alkoxycarbonyl or phenyl optionally substituted with 1 to 3 substituents independently selected from W and one of the carbon atoms can be combined into the group C(O) or C(S);
B is H, C.sub.1 to C.sub.6 alkyl, C.sub.4 to C.sub.7 cycloalkyl alkyl, C.sub.3 to C.sub.6 cycloalkyl optionally substituted with 1 to 2 halogens or 1 to 2 CH.sub.3 ; C.sub.1 to C.sub.6 haloalkyl, C.sub.2 to C.sub.6 alkenyl, C.sub.2 to C.sub.6 haloalkenyl, C.sub.2 to C.sub.6 alkynyl, OR.sub.7, C.sub.2 to C.sub.6 alkoxyalkyl, C.sub.2 to C.sub.6 cyanoalkyl, C.sub.3 to C.sub.8 alkoxycarbonylalkyl, CO.sub.2 R.sub.4, C(O)R.sub.4, C(O)NR.sub.4 R.sub.5, C(S)NR.sub.4 R.sub.5, C(S)R.sub.4, C(S)SR.sub.4, phenyl, phenyl substituted by (R.sub.14)p, benzyl, or benzyl substituted with 1 to 3 substituents independently selected from W;
J is H, C.sub.1 to C.sub.4 alkyl or phenyl optionally substituted with W;
K is H or CH.sub.3 ;
q is 0, 1 or 2;
R.sub.1, R.sub.2, R.sub.3 and R.sub.14 are independently selected from R.sub.4, halogen, CN, N.sub.3, SCN, NO.sub.2, OR.sub.4, SR.sub.4, S(O)R.sub.4, S(O).sub.2 R.sub.4, OC(O)R.sub.4, OS(O).sub.2 R.sub.4, CO.sub.2 R.sub.4, C(O)R.sub.4, C(O)NR.sub.4 R.sub.5, S(O).sub.2 NR.sub.4 R.sub.5, NR.sub.4 R.sub.5, NR.sub.5 C(O)R.sub.4, OC(O)NHR.sub.4, NR.sub.5 C(O)NHR.sub.4 and NR.sub.5 S(O).sub.2 R.sub.4 ; or when m, n or p is 2, R.sub.1, R.sub.2, R.sub.3 or R.sub.14 can independently be taken together as OCH.sub.2 O, OCH.sub.2 CH.sub.2 O or CH.sub.2 CH.sub.2 O, to form a 5 or 6-membered ring, each of which can be independently substituted with 1 to 4 halogen atoms or 1 to 2 methyl groups;
R.sub.4 is selected from H, C.sub.1 to C.sub.6 alkyl, C.sub.3 to C.sub.6 cycloalkyl, C.sub.3 to C.sub.8 alkoxycarbonylalkyl, C.sub.3 to C.sub.6 alkenyl, C.sub.3 to C.sub.6 alkynyl, C.sub.1 to C.sub.6 haloalkyl, C.sub.3 to C.sub.6 haloalkenyl, C.sub.1 to C.sub.6 alkyl substituted with CN, CO.sub.2 CH.sub.3, CO.sub.2 CH.sub.2 CH.sub.3, OCH.sub.3, OCH.sub.2 CH.sub.3, SCH.sub.3, SCH.sub.2 CH.sub.3 or NO.sub.2, or R.sub.4 is phenyl or benzyl, either optionally substituted with W; or R.sub.4 and R.sub.5 can be taken together as (CH.sub.2).sub.4, (CH.sub.2).sub.5 or CH.sub.2 CH.sub.2 OCH.sub.2 CH.sub.2 ;
R.sub.5 is selected from H, C.sub.1 to C.sub.4 alkyl, C.sub.3 to C.sub.4 alkenyl, C.sub.3 to C.sub.4 alkynyl or C.sub.1 to C.sub.4 haloalkyl;
m, n and p are independently 1 to 3;
W is halogen, CN, NO.sub.2, C.sub.1 to C.sub.2 alkyl, C.sub.1 to C.sub.2 haloalkyl, C.sub.1 to C.sub.2 alkoxy, C.sub.1 to C.sub.2 haloalkoxy, C.sub.1 to C.sub.2 alkylthio, C.sub.1 to C.sub.2 haloalkylthio, C.sub.1 to C.sub.2 alkylsulfonyl or C.sub.1 to C.sub.2 haloalkylsulfonyl;
R.sub.6 is H, C.sub.1 to C.sub.4 alkyl, C.sub.1 to C.sub.4 haloalkyl, C.sub.2 to C.sub.4 alkenyl, C.sub.2 to C.sub.4 haloalkenyl, phenyl optionally substituted with W or benzyl optionally substituted with W;
R.sub.7 is H, C.sub.1 to C.sub.4 alkyl, C.sub.2 to C.sub.4 alkenyl, C.sub.2 to C.sub.4
REFERENCES:
patent: 4960784 (1990-10-01), Lahm
Fahmy, deceased Mohamed A. H.
Harrison Charles R.
Lahm George P.
Stevenson Thomas M.
Costello James A.
E. I. Du Pont de Nemours and Company
Ramsuer Robert W.
LandOfFree
N-sulfenylated pyrazolines, compositions and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-sulfenylated pyrazolines, compositions and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-sulfenylated pyrazolines, compositions and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1351724